Neonc Technologies Holdings, Inc.
NTHI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001979414
In the last 90 days, Neonc Technologies Holdings, Inc. insiders filed 11 open-market purchases and 1 sale; 21 institutions reported holding it in 13F filings for Q2 2026, worth $14.3M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 11:02 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $62.1M (155404.4% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 |
|---|---|
| Period end | Dec 31, 2025 |
| Filing | 10-K |
| Reported | – |
| Revenue | $40.0K |
| Operating expenses | $58.3M |
| Research and development | $3.64M |
| Selling, general and administrative | $4.82M |
| Operating income | -$58.2M |
| Interest expense | $2.50M |
| Net income | -$62.1M |
| EPS, basic | $-3.20 |
| EPS, diluted | $-3.20 |
| Weighted shares, basic | 19.4M |
| Weighted shares, diluted | 19.4M |
| Margins and growth | |
| Operating margin | -145637.5% |
| Net margin | -155404.4% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 |
|---|---|
| Period end | Dec 31, 2025 |
| Filing | 10-K |
| Reported | – |
| Cash and equivalents | $58.7K |
| Total current assets | $1.39M |
| Total assets | $2.82M |
| Total current liabilities | $20.0M |
| Total liabilities | $20.3M |
| Shareholders' equity | -$17.5M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 |
|---|---|
| Period end | Dec 31, 2025 |
| Filing | 10-K |
| Reported | – |
| Operating cash flow | -$20.4M |
| Capital expenditures | $500.0K |
| Free cash flow | -$20.9M |
| Stock-based compensation | $35.6M |
| Investing cash flow | -$500.0K |
| Financing cash flow | $20.9M |
| Ratio | |
| Stock-based compensation, % of revenue | 88909.9% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 5, 2026 | 28.9M | +48.1% | SEC |
| Aug 10, 2026 | 25.9M | +35.4% | SEC |
| May 15, 2026 | 26.0M | +36.7% | SEC |
| May 4, 2026 | 25.3M | +32.9% | SEC |
| Mar 30, 2026 | 23.8M | +25.1% | SEC |
| Nov 14, 2025 | 19.5M | – | SEC |
| Aug 18, 2025 | 19.2M | – | SEC |
| May 9, 2025 | 19.0M | – | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.